
Promethean BioPharma opens $3.2m crowdfunding raise as cannabis pain tablet nears TGA decision
Sydney-based biotech Promethean BioPharma has launched a $3.2 million equity crowdfunding campaign as it pushes to make Australia the first country to register an over-the-counter CBD tablet for pain relief, after completing clinical trials and submitting results to the Therapeutic Goods Administration for evaluation. The company has lodged its...



